Jim Simons Catalyst Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 3,251,516 shares of CPRX stock, worth $66.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

3,251,516

Previous 2,956,316 9.99%

Holding current value

$66.1 Million

Previous $71.7 Million 1.58%

% of portfolio

0.1%

Previous 0.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$21.4 - $26.31 $6.32 Million - $7.77 Million	295,200 Added 9.99%	3,251,516 $70.6 Million
Q1 2025 May 14, 2025	BUY	$19.53 - $25.74 $4.89 Million - $6.44 Million	250,200 Added 9.25%	2,956,316 $71.7 Million
Q4 2024 Feb 13, 2025	BUY	$19.73 - $23.93 $3.55 Million - $4.31 Million	180,100 Added 7.13%	2,706,116 $56.5 Million
Q3 2024 Nov 13, 2024	BUY	$15.19 - $21.35 $5.32 Million - $7.48 Million	350,289 Added 16.1%	2,526,016 $50.2 Million
Q2 2024 Aug 09, 2024	BUY	$14.68 - $16.92 $4.22 Million - $4.86 Million	287,300 Added 15.21%	2,175,727 $33.7 Million
Q1 2024 May 13, 2024	BUY	$13.18 - $17.11 $3.84 Million - $4.98 Million	291,000 Added 18.22%	1,888,427 $30.1 Million
Q4 2023 Feb 13, 2024	BUY	$11.78 - $17.29 $3.63 Million - $5.33 Million	308,327 Added 23.92%	1,597,427 $26.9 Million
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $1.57 Million - $2.02 Million	134,200 Added 11.62%	1,289,100 $15.1 Million
Q2 2023 Aug 11, 2023	BUY	$11.5 - $18.08 $745,200 - $1.17 Million	64,800 Added 5.94%	1,154,900 $15.5 Million
Q1 2023 May 12, 2023	SELL	$14.34 - $21.05 $2.03 Million - $2.98 Million	-141,412 Reduced 11.48%	1,090,100 $18.1 Million
Q4 2022 Feb 13, 2023	SELL	$12.25 - $19.5 $12.2 Million - $19.4 Million	-995,000 Reduced 44.69%	1,231,512 $22.9 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $8.44 Million - $18.5 Million	1,194,900 Added 115.83%	2,226,512 $28.6 Million
Q2 2022 Aug 12, 2022	BUY	$6.23 - $8.57 $4.23 Million - $5.81 Million	678,500 Added 192.15%	1,031,612 $7.23 Million
Q1 2022 May 13, 2022	SELL	$5.31 - $8.31 $370,499 - $579,821	-69,774 Reduced 16.5%	353,112 $2.93 Million
Q4 2021 Feb 11, 2022	BUY	$5.21 - $7.45 $1.93 Million - $2.76 Million	370,648 Added 709.54%	422,886 $2.86 Million
Q3 2021 Nov 12, 2021	BUY	$4.85 - $6.04 $253,354 - $315,517	52,238 New	52,238 $277,000
Q2 2020 Aug 13, 2020	SELL	$3.48 - $5.05 $2.57 Million - $3.73 Million	-739,226 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.61 - $5.21 $1.47 Million - $2.94 Million	563,526 Added 320.73%	739,226 $2.85 Million
Q4 2019 Feb 13, 2020	BUY	$3.67 - $5.7 $644,819 - $1 Million	175,700 New	175,700 $659,000

Others Institutions Holding CPRX

# of Institutions

385

Shares Held

102M

Call Options Held

15.8K

Put Options Held

234K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.09B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account